MENU
ERNA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Eterna Therapeutics (ERNA) Ownership - Who owns Eterna Therapeutics?
Industry: @Medical Specialties
Profile
Industry
Medical Specialties
Address
1035 Cambridge Street
Phone
+1 212 582-1199
Employees
8
Web
https://www.eternatx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.79M
P/E Ratio
N/A
Total Cash
2.59M
Projected Growth
N/A
Total Debt
49.21M
Revenue
162K
Risk (Beta)
2.28
Dividend Yield
N/A
Total Cash/Share
0.48
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price
Fundamentals
ERNA
Capitalization
5.79M
P/E Ratio
N/A
Risk (Beta)
2.28
Dividend Yield
N/A
Total Cash
2.59M
Total Cash/Share
0.48
Total Debt
49.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.03%
Revenue
162K
ROE
N/A
Book Value
-8.53M
P/B Ratio
4.85
Cash Flow
N/A
Earnings
-4.43
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
27K
Current Ratio
0.37
Current Revenue Per Employee
5875.00
Dividends Per Share - Security
N/A
EBITDA
-20.12M
Float
N/A
Float - Current
N/A
Gross Income Margin
-102.13
Revenue To Assets
-51.23
Shares Held By Institutions
542K
Shares Outstanding - Current
5.41M
Total Liabilities
55M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-40.390
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biomedical research products in the field of stem cells and regenerative medicine
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1035 Cambridge Street
Phone
+1 212 582-1199
Employees
8
Web
https://www.eternatx.com